The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 14, 2020
Filed:
Dec. 22, 2017
Applicant:
National Institute of Biological Sciences, Beijing, Beijing, CN;
Inventors:
Niu Huang, Beijing, CN;
Shiming Peng, Beijing, CN;
Assignee:
National Institute of Biological Sciences, Beijing, Beijing, CN;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07C 255/34 (2006.01); A61P 25/28 (2006.01); A61P 3/04 (2006.01); C07D 277/30 (2006.01); C07D 277/46 (2006.01); C07D 213/57 (2006.01); C07D 237/14 (2006.01); C07D 239/36 (2006.01); C07D 241/24 (2006.01); C07D 251/16 (2006.01); C07D 241/52 (2006.01); C07D 471/04 (2006.01); C07D 213/80 (2006.01); C07D 241/20 (2006.01); C07D 285/08 (2006.01); C07D 295/185 (2006.01); C07D 241/12 (2006.01); C07D 249/08 (2006.01); C07D 261/12 (2006.01); C07D 239/42 (2006.01); C07D 215/233 (2006.01); C07D 277/56 (2006.01); C07D 249/12 (2006.01); C07D 211/82 (2006.01); C07D 487/04 (2006.01); C07D 235/08 (2006.01); C07D 231/14 (2006.01); C07D 209/08 (2006.01); C07D 239/26 (2006.01); C07D 233/56 (2006.01); C07D 277/24 (2006.01); C07D 261/08 (2006.01); C07D 307/46 (2006.01); C07D 257/04 (2006.01); C07D 213/75 (2006.01); C07D 277/64 (2006.01); C07C 255/43 (2006.01);
U.S. Cl.
CPC ...
C07C 255/34 (2013.01); A61P 3/04 (2018.01); A61P 25/28 (2018.01); C07C 255/43 (2013.01); C07D 209/08 (2013.01); C07D 211/82 (2013.01); C07D 213/57 (2013.01); C07D 213/75 (2013.01); C07D 213/80 (2013.01); C07D 215/233 (2013.01); C07D 231/14 (2013.01); C07D 233/56 (2013.01); C07D 235/08 (2013.01); C07D 237/14 (2013.01); C07D 239/26 (2013.01); C07D 239/36 (2013.01); C07D 239/42 (2013.01); C07D 241/12 (2013.01); C07D 241/20 (2013.01); C07D 241/24 (2013.01); C07D 241/52 (2013.01); C07D 249/08 (2013.01); C07D 249/12 (2013.01); C07D 251/16 (2013.01); C07D 257/04 (2013.01); C07D 261/08 (2013.01); C07D 261/12 (2013.01); C07D 277/24 (2013.01); C07D 277/30 (2013.01); C07D 277/46 (2013.01); C07D 277/56 (2013.01); C07D 277/64 (2013.01); C07D 285/08 (2013.01); C07D 295/185 (2013.01); C07D 307/46 (2013.01); C07D 471/04 (2013.01); C07D 487/04 (2013.01);
Abstract
The invention provides compounds that inhibit FTO (fat mass and obesity), including pharmaceutically acceptable salts, hydrides and stereoisomers thereof. The compounds are employed in pharmaceutical compositions, and methods of making and use, including treating a person in need thereof, particularly obesity, with an effective amount of the compound or composition, and detecting a resultant improvement in the person's health or condition.